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Abstract
Aims: To identify factors related to advanced-stage diagnosis of oral cancer to disclose high-risk groups and fa-
cilitate early detection strategies. 
Study design: An ambispective cohort study on 88 consecutive patients treated  from January 1998 to December 
2003. Inclusion criteria: pathological diagnosis of OSCC (primary tumour) at any oral site and suffering from a tu-
mour at any TNM stage. Variables considered: age, gender, smoking history, alcohol usage, tumour site, macroscopic 
pattern of the lesion, co-existing precancerous lesion, degree of differentiation, diagnostic delay and TNM stage.
Results: A total of 88 patients (mean age 60±11.3; 65.9% males) entered the study. Most patients (54.5%) suffered 
no delayed diagnosis and 45.5% of the carcinomas were diagnosed at early stages (I-II). The most frequent clinical 
lesions were ulcers (70.5%). Most cases were well- and moderately-differentiated (91%). Univariate analyses re-
vealed strong associations between advanced stages and moderate-poor differentiation (OR=4.2; 95%CI=1.6-10.9) 
or tumour site (floor of the mouth (OR=3.6; 95%CI=1.2-11.1); gingivae (OR=8.8; 95%CI=2.0-38.2); and retromolar 
trigone (OR=8.8; 95%CI=1.5-49.1)).
Regression analysis recognised the site of the tumour and the degree of differentiation as significantly associated 
to high risk of late-stage diagnosis.
Conclusions: Screening programmes designed to detect asymptomatic oral cancers should be prioritized. Educa-
tional interventions on the population and on the professionals should include a sound knowledge of the disease 
presentation, specifically on sites like floor of the mouth, gingivae and retromolar trigone. More studies are needed 
in order to analyse the part of tumour biology on the extension of the disease at the time of diagnosis.
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Introduction
Survival rates for oral cancer are very poor (around 50% 
overall), and no remarkable improvements have occurred 
in recent decades despite advances in therapeutic inter-
ventions (1). Variables like age, co-morbidity, immuno-
logical or nutritional status, size and location of the tu-
mour, nodal status, oncogene expression, proliferation 
markers, or DNA content have been assessed as inde-
pendent prognostic markers for oral cancer (2), but stage 
at diagnosis remains as the most important prognostic in-
dicator for oral and oropharyngeal squamous cell cancers 
(SCCs) in such a way that advanced stages are frequently 
associated with high mortality rates (3-5).
Advances in therapy and standards of care are likely to 
have played a role in the moderate increase of survival 
trends, particularly for females and tongue cancer (6,7).
Detecting oral cancer at an early stage is believed to 
be the most effective means of reducing rates of death, 
morbidity and disfigurement from this disease (1), but 
progression in this field is slow: late-stage presentation 
is commonplace despite the existing evidence support-
ing that visual and tactile exploration may ease detec-
tion of oral cancer at early stages (8-10). Evidence also 
suggests that an oral examination of high risk individu-
als may be a cost-effective screening strategy (11).
An important number of studies have assessed the de-
terminants for diagnostic delay (period elapsed since 
the first sign or symptom until definitive diagnosis) de-
spite its controversial part in oral cancer (12-14), but the 
reports aimed at identifying predictors for diagnosis at 
advanced stages are very scarce though tumour stage is 
directly related to mortality by oral cancer.
This study was designed to analyse the hypothetical fac-
tors related to diagnosis of oral cancer at advanced stages 
(III-IV) in order to identify high-risk groups for late-
stage diagnosis and facilitate early detection strategies.
Materials and Methods
An ambispective cohort study was designed to analyse 
those factors related to late-stage oral cancer diagnosis. 
The study sample was made of 88 patients treated at the 
Oral and Maxillofacial Surgery Service of the CHUAC 
from January 1998 to December 2003 that met the fo-
llowing inclusion criteria: pathological diagnosis of 
OSCC (primary tumour) at any oral site and suffering 
from a tumour at any TNM stage.
The primary sites of oral cancer were: buccal mucosa 
(n=5), upper and lower gingiva (n=15), hard palate (n=2), 
tongue (n=32), floor of the mouth (n=24) and retromolar 
trigone (n=10).
The variables considered included age, gender, smoking 
history, alcohol usage, tumour site, macroscopic pattern 
of the lesion (ulcerated, exophytic or mixed), co-exist-
ing precancerous lesion, and degree of differentiation.
The time interval from the self-reported date when oral 
cancer signs and/or symptoms were first noted by the 
patient to the date of definitive pathological diagnosis 
was defined as the total diagnostic delay. In order to 
limit the recall bias inherent to this kind of studies, de-
lay data collected from the patient was also validated by 
those obtained from close relatives. In both situations, 
identical structured interviews were undertaken for all 
cases. The median of total diagnostic times has been 
used as a cut-off point to distinguish between delayed 
and non-delayed cases in a more objective way.
TNM stage was considered as the dependent variable 
(early = tumour-node-metastasis [TNM] stage I or II; 
advanced = TNM stage III or IV). Early stages include 
a variety of tumour sizes (<4 cm) without invasion of 
adjacent structures, and no lymph node or distant me-
tastases. Advanced stages include tumours invading ad-
jacent structures, e.g., through cortical bone, into deep 
(extrinsic) muscle of tongue, maxillary sinus, and skin, 
or a more advanced node status than early stages’ or 
display distant metastases (15). 
 -Statistical analysis
Data were entered on the PASW statics18 statistical 
package and the sample characterized by the variables 
of interest. A descriptive study was conducted where 
quantitative variables were expressed as mean ± stand-
ard deviation; and qualitative ones as absolute frequen-
cy and percentage.  
Means were compared using the Student’s t test after as-
sessing their normality with the Kolmogorov-Smirnov 
test. Those variables that are clinically relevant or were 
significantly related to advanced TNM-stage after uni-
variate analysis (simple logistic regression) were includ-
ed in a multivariate  model (multiple logistic regression). 
The significance level chosen for all tests was p<0.05.
Results
A total of 88 patients (mean age 60±11.3), mostly males 
(65.9%) entered the study. The most frequent tumour 
sites were tongue (36.4%), floor of the mouth (27.3%) 
and gingivae (17%).
The median for the interval between the first sign/symp-
tom to pathological diagnosis was 45 days, and most pa-
tients (54.5%) suffered no delayed diagnosis. A 45.5% 
of the oral carcinomas were diagnosed at early stages 
(I-II). The most frequent clinical lesions were ulcers 
(70.5%), being the cancer associated to a precancerous 
lesion in a 16.5% of the cases. 
Most cases were well- and moderately-differentiated 
(91%) (Table 1). 
Univariate analyses revealed that age (OR=1.0; 
95%CI=0.9-1.0), smoking habit (OR=1.4; 95%CI=0.5- 
3.9), alcohol usage (OR=1.0; 95%CI=0.4-2.6 ), co-exis-
tence of a precancerous lesion (OR=0.6; 95%CI=0.2-
2.1) and the clinical presentation (ulcerated/mixed) 
of the oral carcinoma (OR=2.7; 95%CI=0.7-9.9) were 
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neither significantly associated to diagnosis at ad-
vanced-stages, nor   to TNM-advanced stage (OR=0.7; 
95%CI=0.3-1.6).
On the other hand, male gender was identified as a 
risk factor for late TNM stage at diagnosis (OR=3.8; 
95%CI=1.4-9.6). Strong associations between ad-
vanced stages and moderate-poor differentiation 
(OR=4.2; 95%CI=1.6-10.9) or tumour site (floor of the 
Table 1. Description of the sample (n=88) .
Variables Mean SD Minimum Maximum 
Age 60.3 11.3 38.8 88.1 
n % 95% CI  
Gender 
Female 
Male 
30
58
34.1 
65.9 
23.6-44.5 
55.4-76.3 
Smoking 
Non-Smoker 
Former-Smoker 
Current-Smoker 
22
16
43
27.2 
19.7 
53.0 
16.8-37.4 
10.4-29.0 
41.6-64.5 
Alcohol usage 
Non drinker 
Drinker 
51
27
65.4 
34.6 
54.1-76.5 
23.4-45.8 
Tumour site 
Tongue 
Floor of the mouth 
Gingivae
Buccal Mucosa 
Retromolar trigone 
Hard palate 
32
24
15
5
10
2
36.4 
27.3 
17.0 
5.7 
11.4 
2.3 
25.7-46.9 
17.3-37.1 
8.6-25.4 
1.8-12.7 
4.1-18.5 
0.2-7.9 
TNM Stage 
Stage I 
Stage II 
Stage III 
Stage IV 
10
30
14
34
11.4 
34.1 
15.9 
38.6 
4.1-18.5 
23.6-44.5 
7.6-24.1 
27.8-49.3 
Tumour size 
T1
T2
T3
T4
12
43
10
23
13.6 
48.9 
11.4 
26.1 
5.8-21.3 
37.8-59.8 
4.1-18.5 
16.3-35.8 
Neck node status 
Negative (N0)
Positive(N1,2,3)
61
27
69.3 
30.7 
59.1-79.5 
20.4-40.8 
Macroscopic features 
Exophytic 
Mixed 
Ulcerated 
12
11
55
15.3 
14.1 
70.5 
6.7-24.0 
5.7-22.4 
59.7-81.2 
Degree of differentiation 
Well
Moderate 
Poor
29
51
7
33.0 
58.0 
8.0 
22.8-43.8 
47.6-69.5 
1.7-14.3 

mouth (OR=3.6; 95%CI=1.2-11.1); gingivae (OR=8.8; 
95%CI=2.0-38.2); and retromolar trigone (OR=8.8; 
95%CI=1.5-49.1)) have also been identified by univari-
ate analysis (Table  2).
Regression analysis excluded “gender” from the mul-
tivariate model, remaining tumour site and degree of 
differentiation significantly associated to high risk of 
late-stage diagnosis (Table 3).
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Table 2. Patient characteristics distribution according to TNM-stage at diagnosis. Simple logistic regres-
sion analysis. 
Variables  Early stage 
(I-II) 
n=40 (45.5%) 
Advanced stage 
(III-IV) n=48 
(54.5%) 
p-value Odds Ratio (95%CI) 
Age (yrs) 
Mean ±SD 59.4±11.0 61.1± 11.6 0.5 1.0 (0.9-1.0) 
Gender 
Female 
Male 
20 (66.7) 
20 (34.5) 
10 (33.3) 
38 (65.5) 0.005 
1.0 (Referent) 
3.8 (1.4-9.6) 
Tobacco use 
Non-smoker 
Smoker 
11 (50.0) 
24 (40.7) 
11 (50.0) 
35 (59.3) 0.4 
1.0 (Referent) 
1.4 (0.5-3.9) 
Alcohol Use 
Non-drinker 
Drinker 
12 (44.4) 
22 (43.1) 
15 (55.6) 
29 (56.9) 0.9 
1.0 (Referent) 
1.0 (0.4-2.6) 
Associated 
precancerous lesion  
No
Yes
28 (43.1) 
7 (53.8) 
37 (56.9) 
6 (46.2) 0.5 
1.0 (Referent) 
0.6 (0.2-2.1) 
Macroscopic features 
Exophytic 
Mixed+Ulcerated 
8 (66.7) 
28 (42.4) 
4 (33.3) 
38 (57.6) 0.1 
1.0 (Referent) 
2.7 (0.7-9.9) 
Location
Tongue 
Floor of the mouth 
Gingivae
Buccal mucosa 
Retromolar trigone 
Hard palate 
22 (68.8) 
9 (37.5) 
3 (20.0) 
3 (60.0) 
2 (20.0) 
1 (50.0) 
10 (31.1) 
15 (62.5) 
12 (80.0) 
2 (40.0) 
8 (80.0) 
1 (50.0) 
0.02 
0.004 
0.7 
0.01 
0.6 
1.0 (Referent) 
3.6 (1.2-11.1) 
8.8 (2.0-38.2) 
1.4 (0.2-10.1) 
8.8 (1.5-49.1) 
2.2 (0.1-38.8) 
Diagnostic delay 
No
Yes
20 (41.7) 
20 (50.0) 
28 (58.3) 
20 (50.0) 0.4 
1.0 (Referent) 
0.7 (0.3-1.6) 
Degree of 
differentiation  
Well
Moderate 
Poor
20 (69.0) 
19 (37.3) 
1 (14.3) 
9 (31.0) 
32 (62.7) 
6 (85.7) 
0.008 
0.02 
1.0 (Referent) 
3.7 (1.4-9.8) 
13.3 (1.3-127.5) 

Table 3. Multiple logistic regression analysis of the association between advanced staged and 
patients/tumours characteristics. 
Characteristics B S.E. Wald p-value Odds Ratio 
(95%CI)
Constant -2.88 0.7 14.4 0.000 0.056 
Gender 
Female 
Male 0.98 0.58 2.82 0.09 2.6 (0.8-8.4) 
Location of the tumour 
Tongue
Floor of the mouth 
Other
1.57 
2.37 
0.71 
0.68 
4.8 
11.9 
0.028 
0.001 
4.8 (1.1-19.5) 
10.7 (2.8-41.3) 
Degree of differentiation 
Well 
Moderate
Poor
1.32 
4.11 
0.58 
1.30 
5.2 
9.9 
0.022 
0.002 
3.7 (1.2-11.7) 
61.1 (4.7-786.7) 

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Discussion
The current recommendations to screen for oral cancer 
at every routine check-up is not practical and has not 
produced the intended results. Selective opportunistic 
screening may be a more realistic and effective solution. 
Detection of oral and oropharyngeal SCCs during a non-
symptom-driven examination has proved an association 
to lower stage at diagnosis, in the same way as patients 
with a regular primary care dentist are significantly more 
likely to be diagnosed at early stages (4,16).
Unfortunately, about a 60% of cancers are identified 
late (stages III or IV) with survival rates ranging from 
10% to 40% after 5 years (17,18). Up to a 54.5% of the 
patients in this series were diagnosed at late stages, and 
recognition of predictors for advanced-stage diagnosis 
could permit the development of strategies aimed at im-
proving this percentage.
Age, gender, and tobacco and alcohol consumption did 
not behaved as variables linked to late-stage diagnosis; 
as were not previously associated to professional or pa-
tient-related diagnostic delays (19,20). The existence of 
precancerous lesions associated to the tumour did not 
seem to modify the extension of the disease at the mo-
ment of diagnosis, despite that proliferative verrucous 
leukoplakia or the presence of mild or moderate epi-
thelial dysplasia at the margins of a surgically removed 
OSCC carries a significant risk of local recurrence and 
modifying prognosis (21).
Ulcerated-type OSCC were diagnosed mostly (up to a 
60%) at stages III-IV, but this association did not reach 
statistical signification. Moreover, the predictive value 
for survival of the lesion clinical appearance is contro-
versial, although it is accepted that ulcerated lesions im-
ply poorer survival rates (22).
Previous reports have described the association be-
tween primary tumour site and delayed diagnosis or 
diagnosis at advanced stages (23): tongue, buccal mu-
cosa and lip have been recognised as locations that fa-
vour early-stage diagnosis (18), whereas the floor of the 
mouth and the retromolar trigone have been linked to 
diagnosis at advanced stages; locations like palate or 
gingivae showed contradictory results (18,24). Our data 
show that the floor of the mouth, gingivae and retromo-
lar trigone behaved as an independent prognostic fac-
tor for late stage at diagnosis. These findings may well 
be explained by the fact that patient’s self-perception 
and self-exploration abilities depend on the site of the 
tumour (25), and also because gingival locations are as-
sociated to advanced stages at diagnosis (late diagnosis) 
due to the early invasion of the adjacent tissue (T4 pri-
mary tumour) (26).
Advanced-stage diagnosis in oral cancer has tradition-
ally been attributed to delays in reaching a diagnosis, 
as patients at advance tumour stages are more likely to 
have longer patient and professional delays than those 
at early stages (27). However, the lack of sound scien-
tific evidence supporting the existence of an association 
between diagnostic delay, extent of the disease (III-IV 
TNM stages) and lower survival rates is evident (12-14). 
This fact is probably related to a series of limitations 
and methodological flaws identified in the published re-
ports to date, mainly related to heterogeneity in both the 
definition and measurement of diagnostic delay, the ret-
rospective nature of these studies and also to a memory 
bias of the patients (12,13).
In this study, diagnostic delay was not significantly 
linked to advanced stage at diagnosis; thus the quick-
ness in obtaining a diagnosis does not guarantee an 
early-stage tumour, although delay in the diagnosis of a 
neoplasm is universally considered unacceptable.
On the other hand, poor differentiation of the tumour 
(biologically more aggressive) behaved as an indepen-
dent risk factor for diagnosis at stages III-IV. The tumour 
growth rate may play the role of a confounding factor 
in the relationship between diagnostic delay and disease-
stage or survival, as patients with aggressive tumours 
and bad prognosis do not usually present diagnostic delay 
whereas tumours with low proliferation rates elicit good 
prognosis despite  long diagnostic delays (28). Unfortu-
nately, the evidence on tumour proli-feration activity that 
could corroborate this hypothesis is scarce.
This paradoxical circumstance has previously been de-
scribed  in breast, cervix, lung, colon, renal, and urethral 
cancers and seems to suggest that stage at diagnosis is 
affected more by the biology of the cancer (rapid tumour 
growth) than by diagnostic delay (28,29). These results 
seem to suggest that the stage of oral cancer at the time 
of diagnosis is affected more by the biology of the cancer 
(degree of differentiation) than by diagnostic delay.
Taking into account that early diagnosis is a foremost 
step for reducing cancer mortality, it is concluded that 
the efforts aimed at early diagnosis of oral cancer should 
be prioritized towards screening programmes designed 
to detect the disease during its asymptomatic phases. 
Educational interventions on the population, particu-
larly focused on risk groups (self-exploration) and on 
the professionals (clinician’s index of suspicion) should 
include a sound knowledge of the disease presentation, 
specifically on sites like floor of the mouth, gingivae 
and retromolar trigone. More studies are needed in or-
der to analyse the part of tumour biology on the exten-
sion of the disease at the time of diagnosis.
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